Influence of minor groove binders on the eukaryotic topoisomerase II cleavage reaction with 41 base pair model oligonucleotides Achim BellLeonhard KittlerChristoph Zimmer OriginalPaper Pages: 271 - 284
Evaluation of 2,6-Diamino-N-([1-(1-oxotridecyl)-2-piperidinyl]methyl) hexanamide (NPC 15437), a protein kinase C inhibitor, as a modulator of P-glycoprotein-mediated resistancein vitro Edward C. ShaMichael C. ShaScott H. Kaufmann OriginalPaper Pages: 285 - 294
Inhibition of the epidermal growth factor receptor tyrosine kinase by PD153035 in human A431 tumors in athymic nude mice Mark W. KunkelKenneth E. HookWilbur R. Leopold OriginalPaper Pages: 295 - 302
Automated imaging and quantitation of tumor cells and CFU-GM colonies in microcapillary cultures: toward therapeutic index-based drug screening Martin J. Murphy Jr.Fred FushimiEmilio Barberá-Guillem OriginalPaper Pages: 303 - 314
Phase I trial of high-dose infusional hydroxyurea, high-dose infusional 5-fluorouracil and recombinant interferon-α-2a in patients with advanced malignancies Scott WadlerHilda HaynesPeter H. Wiemik OriginalPaper Pages: 315 - 320
Phase I trial of Adozelesin using the treatment schedule of daily × 5 every 3 weeks Brenda J. FosterPatricia M. LoRussoLaurence H. Baker OriginalPaper Pages: 321 - 326
Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane T. SchillingK. B. KepplerA. -R. Hanauske OriginalPaper Pages: 327 - 332
Phase I trial of intravenous carboplatin added to oral etoposide and oral cyclophosphamide for stage IV non-small cell lung cancer Steven M. GrunbergJohn ValentinePaul Unger OriginalPaper Pages: 333 - 335
A phase II study of thioTEPA in children with recurrent solid tumor malignancies: a Children's Cancer Group study J. Russell GeyerFrank M. BalisW. Archie Bleyer OriginalPaper Pages: 337 - 342
Phase II study of docetaxel (taxotere) in patients with previously untreated extensive small cell lung cancer Jean LatreilleYvon CormierElizabeth A. Eisenhauer OriginalPaper Pages: 343 - 345
Phase II trial of topotecan in advanced or metastatic adenocarcinoma of the pancreas Richard M. ScherRichard KosierowskiPeter J. O'Dwyer OriginalPaper Pages: 347 - 354
Phase II trial of ZD1694 (TomudexTM) in patients with advanced pancreatic cancer Richard PazdurNeal J. MeropolJames L. Abbruzzese Brief Report Pages: 355 - 358
Phase II trial of edatrexate in patients with metastatic colorectal cancer Gerald H. ClamonCharles E. Riggs Jr.Raymond J. Hohl OriginalPaper Pages: 359 - 361
Phase II trial of trimetrexate in advanced esophageal cancer: A southwest oncology group study Thomas R. FlemingThomas D. BrownJohn S. Macdonald OriginalPaper Pages: 363 - 365